Therapeutic effect of lenampicillin (KBT-1585) on respiratory tract infection

Sehchi Aonuma, Kotaro Oizumi, Kikuo Onuma, Akira Watanabe, Masako Sasaki, Kiyoshi Konno, Kosaku Nagai, Tsukasa Yoshida

    Research output: Contribution to journalArticle

    Abstract

    32 patients with respiratory tract infections, four with acute pharyngitis, two with acute tonsillitis, four with acute pharyngitis and acute bronchitis, 12 with acute bronchitis, seven with chronic respiratory tract infection and three with acute pneumonia, were treated with oral administration of 750 to 1000mg a day of lenampicillin (KBT-1585). Clinical response was good in 22 patients, fair in seven and poor in three. No adverse symptom and sign was noted during administration of KBT-1585. Slight elevation of GPT was observed in two cases.

    Original languageEnglish
    Pages (from-to)233-238
    Number of pages6
    JournalChemotherapy
    Volume32
    DOIs
    Publication statusPublished - 1984 Jan

    ASJC Scopus subject areas

    • Pharmacology (medical)
    • Infectious Diseases
    • Pharmacology
    • Drug Discovery
    • Oncology

    Fingerprint Dive into the research topics of 'Therapeutic effect of lenampicillin (KBT-1585) on respiratory tract infection'. Together they form a unique fingerprint.

  • Cite this

    Aonuma, S., Oizumi, K., Onuma, K., Watanabe, A., Sasaki, M., Konno, K., Nagai, K., & Yoshida, T. (1984). Therapeutic effect of lenampicillin (KBT-1585) on respiratory tract infection. Chemotherapy, 32, 233-238. https://doi.org/10.11250/chemotherapy1953.32.Supplement8_233